Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1214717 BOSTON, MA
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$13,469,568
+$11,638,581 QoQ
Shares Held
2,062,721
+231.2% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 111 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ACHV ranks #169 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ACHV

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,469,568 2,062,721
2026-03-31 $1,830,987 622,785
2025-12-31 $2,980,065 599,611
2025-09-30 $1,596,977 506,977
2025-06-30 $818,571 362,200
2025-03-31 $2,053,139 768,966
2024-12-31 $2,660,574 755,845
2024-09-30 $3,550,775 749,109
2024-06-30 $3,292,984 700,635
2024-03-31 $940,867 206,784
2023-12-31 $761,891 184,925
2023-09-30 $795,177 184,925
2023-06-30 $842,274 162,288
2023-03-31 $1,227,284 180,483
2022-12-31 $209,144 85,365
2022-09-30 $282,328 85,554
2022-06-30 $417,503 85,554
2022-03-31 $647,643 85,554
2021-12-31 $665,610 85,554
2021-09-30 $727,209 85,554
2021-06-30 $508,887 56,669
2021-03-31 $339,178 29,290
2020-06-30 $14,454 36,136
2020-03-31 $11,924 36,136